Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.36 |
| ▸ | KDM4A | O75164 | 1/20 | 0.36 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.36 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | GBA1 | P04062 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14839871 | 1.00 | LMNA (0.50) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| Isostearyl Alcohol SCHEMBL8716 | 1.00 | LMNA (0.50) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL9620428 | 1.00 | LMNA (0.50) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL352004 | 1.00 | LMNA (0.50) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL3778363 | 1.00 | LMNA (0.50) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL26877 | 1.00 | — | — | |
| SCHEMBL20345 | 1.00 | LMNA (0.50) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL5498280 | 1.00 | LMNA (0.50) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL852700 | 1.00 | LMNA (0.50) | LMNAALDH1A1TSHRHSD17B10MEN1 | |
| SCHEMBL19468481 | 1.00 | LMNA (0.50) | LMNAALDH1A1TSHRHSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 336 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117327930-B | Method for recovering vanadium from primary shale stone coal | 中国恩菲工程技术有限公司 | 2024-02-27 | — | — | CN | claimed |
| CN-117327930-A | Method for recovering vanadium from primary shale stone coal | 中国恩菲工程技术有限公司 | 2024-01-02 | — | — | CN | claimed |
| EP-0452941-B1 | Use of isomonools in the treatment and prophylaxis of cancer | DAI ICHI KOGYO SEIYAKU CO LTD (JP) | 1996-03-06 | — | — | EP | claimed |
| EP-0388197-B1 | Production of terephthalate esters by degradative transesterification of scrap or virgin terephthalate polyesters | SYNERGISTICS IND LTD (CA) | 1995-06-21 | — | — | EP | claimed |
| US-5162304-A | Higher Isoalkyl Alcohols | DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) | 1992-11-10 | — | — | US | claimed |
| CN-122080387-A | Alkylene oxide derivative and preparation method and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| CN-115667599-B | Heat storage composition | 住友化学株式会社 | 2026-05-12 | — | — | CN | disclosed |
| EP-4726101-A1 | WATER REPELLENT COMPOSITION AND METHOD FOR PRODUCING SAME | Daikin Industries, Ltd. (JP) | 2026-04-15 | — | — | EP | disclosed |
| US-20260098377-A1 | FIBER STRUCTURE | DAIKIN INDUSTRIES, LTD. (JP) | 2026-04-09 | — | — | US | disclosed |
| US-12553176-B2 | Treatment agent for carbon fiber precursor, composition containing treatment agent for carbon fiber precursor, and carbon fiber precursor | TAKEMOTO OIL & FAT CO., LTD. (JP) | 2026-02-17 | — | — | US | disclosed |
| US-20260035553-A1 | STYRENE-BASED RESIN COMPOSITION AND MOLDED ARTICLE | PS JAPAN CORPORATION (JP) | 2026-02-05 | — | — | US | disclosed |
| US-12540245-B2 | Water repellent composition, method for producing water repellent composition, and fiber product | MITSUI CHEMICALS, INC. (JP) | 2026-02-03 | — | — | US | disclosed |
| US-5369106-A | N-acryloylpiperazine derivatives, their preparation and their use of PAF antagonists | SANKYO COMPANY, LIMITED (JP) | 1994-11-29 | — | — | US | disclosed |
| US-5283311-A | Fatty prepolymers and fatty-modified polyisocyanates as internal mold release agents | BASF CORPORATION (US) | 1994-02-01 | — | — | US | disclosed |
| US-5192766-A | Platelet activating factor antagonist | SANKYO COMPANY, LIMITED (JP) | 1993-03-09 | — | — | US | disclosed |
| WO-1993002666-A1 | SELF-STABILISED MULTIPHASE EMUSION STRUCTURES | THOREL JEAN NOEL (FR) | 1993-02-18 | — | — | WO | disclosed |
| US-5162304-A | Higher Isoalkyl Alcohols | DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) | 1992-11-10 | — | — | US | disclosed |
| WO-1991018905-A1 | RADICICOL DERIVATIVES, THEIR PREPARATION AND THEIR ANTI-TUMOR ACTIVITY | SANKYO COMPANY LIMITED (JP) | 1991-12-12 | — | — | WO | disclosed |
| EP-0460950-A1 | Radicicol derivatives, their preparation and their anti-tumour activity | Sankyo Company Limited (JP) | 1991-12-11 | — | — | EP | disclosed |
| EP-0452941-A2 | Use of isomonools in the treatment and prophylaxis of cancer | DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) | 1991-10-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260098377-A1 | FIBER STRUCTURE | SMC2, SMCHD1, SMC4 | LMNA 3868/4885ALDH1A1 3187/4885TSHR 4023/4885 |
| US-12540245-B2 | Water repellent composition, method for producing water repellent composition, and fiber product | AFF1, RER1, NAF1 | LMNA 3449/4885ALDH1A1 1894/4885TSHR 1780/4885 |
| US-20260035553-A1 | STYRENE-BASED RESIN COMPOSITION AND MOLDED ARTICLE | REV1, MAT1A, ARCN1 | LMNA 1743/4885ALDH1A1 27/4885TSHR 3815/4885 |
| US-12553176-B2 | Treatment agent for carbon fiber precursor, composition containing treatment agent for carbon fiber precursor, and carbon fiber precursor | FLNA, EMD, WDR82 | LMNA 603/4885ALDH1A1 3433/4885TSHR 2383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.